Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 46 to 60 of 67 results for venous thrombosis

  1. Subfascial endoscopic perforator vein surgery (IPG59)

    Evidence-based recommendations on subfascial endoscopic perforator vein surgery. This involves cutting and closing off, or heating and sealing, perforator veins so that blood can no longer go through them.

    Interventional procedures guidance
    Published
    27 May 2004
    View recommendations

    Sections for IPG59

  2. Transilluminated powered phlebectomy for varicose veins (IPG37)

    Evidence-based recommendations on transilluminated powered phlebectomy for varicose veins. This involves using a special light passed underneath the skin to see the veins and removing them by suction.

    Interventional procedures guidance
    Published
    28 January 2004
    View recommendations

    Sections for IPG37

  3. Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism (TA354)

    Evidence-based recommendations on edoxaban (Lixiana) for treating deep vein thrombosis and pulmonary embolism in adults and preventing them happening again.

    Technology appraisal guidance
    Published
    26 August 2015
    View recommendations

    Sections for TA354

  4. Abortion care (NG140)

    This guideline covers care for women of any age (including girls and young women under 18) who request an abortion. It aims to improve the organisation of services and make them easier for women to access. Detailed recommendations on conducting abortions at different gestational stages are also included, to ensure that women get the safest and most effective care possible.

    NICE guideline
    Published
    25 September 2019
    View recommendations

    Sections for NG140

  5. HemaClear for bloodless surgical field during limb surgery (MIB187)

    NICE has developed a medtech innovation briefing (MIB) on HemaClear for bloodless surgical field during limb surgery .

    Medtech innovation briefing
    Published
    15 July 2019

  6. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension (IPG554)

    Evidence-based recommendations on balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension in adults. This involves inserting and inflating a balloon in blocked blood vessels in the lungs to improve blood flow.

    Interventional procedures guidance
    Published
    27 April 2016
    View recommendations

    Sections for IPG554

  7. Current evidence on the safety of percutaneous mechanical thrombectomy for acute deep vein thrombosis (DVT) of the leg shows there are well-recognised but infrequent complications. For acute iliofemoral DVT the evidence on efficacy is limited in quality and quantity, therefore this procedure should only be used with  special arrangements   for clinical governance, consent, and audit or research.

    the safety of percutaneous mechanical thrombectomy for acute deep vein thrombosis (DVT) of the leg shows there are well-recognised but...

    Research recommendation
    Published
    27 May 2020

  8. Effects of HRT on venous thromboembolism risk:- How does the preparation of HRT affect the risk of venous thromboembolism (VTE)?

    Question Effects of HRT on venous thromboembolism risk:- How does the preparation of HRT affect the risk of venous...

    Research recommendation
    Published
    11 December 2015

  9. Direct oral anticoagulants for people with lower limb immobilisation:- What is the clinical and cost effectiveness of direct oral anticoagulants for preventing VTE in people with lower limb immobilisation?

    applicable) Why this is important:- The Computerized registry of patients with venous thromboembolism (RIETE) study, a multicentre...

    Research recommendation
    Published
    15 November 2018

  10. Dose strategies for people who are obese:- What is the clinical and cost effectiveness of weight-based dose-adjustment strategies of lowmolecular-weight heparin (LMWH) compared with fixed-dose strategies of LMWH for preventing VTE in people who are very obese (BMI over 35) who are admitted to hospital or having day procedures (including surgery and chemotherapy)?

    of biological measures rather than clinical outcomes such as deep vein thrombosis (DVT) and bleeding events. It is important that there...

    Research recommendation
    Published
    15 November 2018

  11. There have been no head-to-head trials of rivaroxaban compared with a low molecular weight heparin for people who have cancer and experience an acute pulmonary embolism or deep vein thrombosis. As in NICE technology appraisal guidance 261 it is recommended that further research should be carried out.

    who have cancer and experience an acute pulmonary embolism or deep vein thrombosis. As in NICE technology appraisal guidance 261 it is...

    Research recommendation
    Published
    9 June 2015

  12. Duration of prophylaxis for elective total hip replacement surgery:- What is the clinical and cost effectiveness of standard versus extended duration pharmacological prophylaxis for preventing VTE in people undergoing elective total hip replacement surgery?

    Comes from guidance Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or...

    Research recommendation
    Published
    15 November 2018

  13. The Juxta CURES adjustable compression system for treating venous leg ulcers (MIB25)

    NICE has developed a medtech innovation briefing (MIB) on the Juxta CURES adjustable compression system for treating venous leg ulcers

    Medtech innovation briefing
    Published
    25 March 2015

  14. Aspirin prophylaxis for people with fragility fractures of the pelvis, hip or proximal femur:- What is the clinical and cost effectiveness of aspirin alone versus other pharmacological and/or mechanical prophylaxis strategies (alone or in combination) for people with fragility fractures of the pelvis, hip or proximal femur?

    Comes from guidance Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or...

    Research recommendation
    Published
    15 November 2018

  15. Risk assessment:- What is the accuracy of individual risk assessment tools in predicting the risk of venousthromboembolism (VTE) and risk of bleeding in people admitted to hospital?

    Comes from guidance Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or...

    Research recommendation
    Published
    15 November 2018